发明名称 PHARMACEUTICAL COMPOSITION REPRESENTING SYSTEM OF CONTROLLED DELIVERY OF A MEDICAMENT FOR ORAL ADMINISTRATION, PROVIDING TIME AND LOCAL CONTROL
摘要 A pharmaceutical composition in the form of tablets or capsules provides a combination of temporal and spatial control of drug delivery to a patient for effective therapeutic results. The pharmaceutical composition comprises a drug, a gas generating component, a swelling agent, a viscolyzing agent, and optionally a gel forming polymer. The swelling agent belongs to a class of compounds known as superdisintegrants (e.g., cross-linked polyvinylpyrrolidone or sodium carboxymethylcellulose). The viscolyzing agent initially and the gel forming polymer thereafter form a hydrated gel matrix which entraps the gas, causing the tablet or capsule to float so that it is retained in the stomach or upper part of the small intestine (spatial control). At the same time, the hydrated gel matrix creates a tortuous diffusion path for the drug, resulting in sustained release of the drug (temporal control). A preferred once daily ciprofloxacin formulation comprises 69.9 % ciprofloxacin base, 0.34 % sodium alginate, 1.03 % xanthan gum, 13.7 % sodium bicarbonate, 12.1 % cross-linked polyvinylpyrrolidone, and optionally other pharmaceutical excipients, the formulation being in the form of a coated or uncoated tablet or capsule.
申请公布号 EA005767(B1) 申请公布日期 2005.06.30
申请号 EA20030000847 申请日期 1999.01.19
申请人 RANBAXY LABORATORIES LIMITED 发明人 TELWAR, NARESH;SEN, HIMARDI;STANIFORTH, JOHN
分类号 A61K9/00;A61K9/22;A61K9/52;A61K31/341;A61K31/401;A61K31/4709;A61K31/52;A61K31/554;A61K45/08;A61K47/00;A61K47/02;A61K47/04;A61K47/12;A61K47/18;A61K47/20;A61K47/22;A61K47/30;A61K47/32;A61K47/36;A61K47/38;A61P3/04;A61P3/06;A61P9/00;A61P11/00;A61P19/06;A61P29/00;A61P31/00;A61P31/10;A61P31/12;A61P33/00;A61P35/00;A61P37/06;(IPC1-7):A61K9/22 主分类号 A61K9/00
代理机构 代理人
主权项
地址